Latest News: Alzheimer’s Drug
Japan’s Eisai Seeks US Fast Track on Alzheimer’s Drug
Saturday April 9, 2022
Eisai's lecanemab, like Aduhelm, is a monoclonal antibody designed to remove beta-amyloid, a type of protein fragment that accumulates in brains
Eisai outpaces Biogen in Alzheimer’s drug stock boost
Tuesday June 8, 2021
Japan’s Eisai saw its US listed shares rise 56% – up by more than Biogen’s 38% jump after US regulators...
ABOUT AF
RESOURCES
LEGAL + PRIVACY
DISCLAIMER
Asia Financial is owned by Capital Link International Holdings Ltd, 902, Wilson House 19-27 Wyndham Street, Central, Hong Kong. www.capitallinkintl.com
